Eli Lilly & Co. (NYSE:LLY)

CAPS Rating: 3 out of 5

The Company discovers, develops, manufactures and sells products in one of its business segment of pharmaceutical products to prevent and treat human diseases.

Recs

1
Player Avatar cibient (25.23) Submitted: 5/26/2011 12:08:45 PM : Outperform Start Price: $33.86 LLY Score: +37.60

5% divy, sustainable payout ratio (45% according to Yahoo! Finance), MFI stats from MagicDiligence.com:Results for ticker 'LLY' (Eli Lilly and Company):Earnings Yield:   16.1%MFI Return on Capital:   48.2%MagicDiligence Research for 'LLY':Research Available for LLY!Instant Diligence:The Earnings Yield of 16.1% is Very High.The MFI Return on Capital of 48.2% is High.Near-term Financial Health appears to be Excellent. The current ratio is 2.01.Calculations:(for quarter ended 2011-03-31)Market Cap   =   Stock_Price * Shares   =   38.08 * 1112.00   =   42344.96Excess Cash   =   Cash - MAX(0; (Current Liabilities - Current Assets + Cash))   =   6713.10 - MAX(0; (7651.80 - 15354.30 + 6713.10))   =   6713.10Enterprise Value   =   Market Cap + Total Debt - Excess Cash   =   42344.96 + 6672.30 - 6713.10   =   42304.16MFI Invested Capital   =   Total Assets - Goodwill - Intangibles - Current Liabilities + Short Term Debt - Excess Cash   =   31695.30 - 0.00 - 4731.30 - 7651.80 + 1539.90 - 6713.10   =   14139.00Earnings Yield   =   Operating Earnings / Enterprise Value   =   6812.10 / 42304.16   =   0.161 (16.1%)MFI Return on Capital   =   Operating Earnings / MFI Invested Capital   =   6812.10 / 14139.00   =   0.482 (48.2%)

Featured Broker Partners


Advertisement